Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease.

Nature 2014 Jan 11;505(7484):550-554. Epub 2013 Dec 11.

Department of Psychiatry, Washington University, St. Louis, MO, USA.

Genome-wide association studies (GWAS) have identified several risk variants for late-onset Alzheimer's disease (LOAD). These common variants have replicable but small effects on LOAD risk and generally do not have obvious functional effects. Low-frequency coding variants, not detected by GWAS, are predicted to include functional variants with larger effects on risk. To identify low-frequency coding variants with large effects on LOAD risk, we carried out whole-exome sequencing (WES) in 14 large LOAD families and follow-up analyses of the candidate variants in several large LOAD case-control data sets. A rare variant in PLD3 (phospholipase D3; Val232Met) segregated with disease status in two independent families and doubled risk for Alzheimer's disease in seven independent case-control series with a total of more than 11,000 cases and controls of European descent. Gene-based burden analyses in 4,387 cases and controls of European descent and 302 African American cases and controls, with complete sequence data for PLD3, reveal that several variants in this gene increase risk for Alzheimer's disease in both populations. PLD3 is highly expressed in brain regions that are vulnerable to Alzheimer's disease pathology, including hippocampus and cortex, and is expressed at significantly lower levels in neurons from Alzheimer's disease brains compared to control brains. Overexpression of PLD3 leads to a significant decrease in intracellular amyloid-β precursor protein (APP) and extracellular Aβ42 and Aβ40 (the 42- and 40-residue isoforms of the amyloid-β peptide), and knockdown of PLD3 leads to a significant increase in extracellular Aβ42 and Aβ40. Together, our genetic and functional data indicate that carriers of PLD3 coding variants have a twofold increased risk for LOAD and that PLD3 influences APP processing. This study provides an example of how densely affected families may help to identify rare variants with large effects on risk for disease or other complex traits.

Download full-text PDF

Source
http://dx.doi.org/10.1038/nature12825DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4050701PMC
January 2014
55 Reads
129 Citations
42.351 Impact Factor

Publication Analysis

Top Keywords

alzheimer's disease
24
coding variants
16
risk alzheimer's
12
cases controls
12
variants large
12
variants
10
risk
9
european descent
8
disease
8
effects load
8
controls european
8
aβ42 aβ40
8
pld3 leads
8
effects risk
8
large effects
8
low-frequency coding
8
large load
8
extracellular aβ42
8
load risk
8
pld3
7

References

(Supplied by CrossRef)
Article in J. Neurochem.
A Goate et al.
J. Neurochem. 2012
Article in Nature
T Jonsson et al.
Nature 2012
Article in Neurobiol. Aging
BA Benitez et al.
Neurobiol. Aging 2013
Article in N. Engl. J. Med.
BA Benitez et al.
N. Engl. J. Med. 2013
Article in N. Engl. J. Med.
R Guerreiro et al.
N. Engl. J. Med. 2013
Article in PLoS ONE
C Cruchaga et al.
PLoS ONE 2012
Article in JAMA Neurol.
M Harms et al.
JAMA Neurol. 2013
Article in PLoS Genet.
EM Wijsman et al.
PLoS Genet. 2011
Article in Neurology
JC Breitner et al.
Neurology 1999

Similar Publications